- Previous Close
5.12 - Open
5.24 - Bid 4.95 x 100
- Ask 5.29 x 100
- Day's Range
5.11 - 5.24 - 52 Week Range
3.50 - 10.00 - Volume
3,529 - Avg. Volume
186,031 - Market Cap (intraday)
242.17M - Beta (5Y Monthly) --
- PE Ratio (TTM)
85.17 - EPS (TTM)
0.06 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. It offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company also exports its products to Vietnam, Pakistan, and Egypt. The company was founded in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.
www.jlzybio.com278
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: ZYBT
View MorePerformance Overview: ZYBT
Trailing total returns as of 4/15/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ZYBT
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ZYBT
View MoreValuation Measures
Market Cap
242.64M
Enterprise Value
253.46M
Trailing P/E
86.81
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
9.28
Price/Book (mrq)
6.28
Enterprise Value/Revenue
9.74
Enterprise Value/EBITDA
32.22
Financial Highlights
Profitability and Income Statement
Profit Margin
10.69%
Return on Assets (ttm)
3.82%
Return on Equity (ttm)
7.15%
Revenue (ttm)
189.75M
Net Income Avi to Common (ttm)
20.29M
Diluted EPS (ttm)
0.06
Balance Sheet and Cash Flow
Total Cash (mrq)
8.52M
Total Debt/Equity (mrq)
24.98%
Levered Free Cash Flow (ttm)
-21.93M